Literature DB >> 19657198

St. John's wort - an overview.

Klaus Linde1.   

Abstract

This article aims to summarize the current state of knowledge on St. John's wort (Hypericum perforatum L.) which is one of the oldest and best investigated medicinal herbs. Dried alcoholic extracts are the most important preparations on the market although a variety of other preparations are available. Depressive disorders according to modern diagnostic standards are the best known and most widely investigated indication although the more traditional, broader indication of 'psycho-vegetative disorders, depressive disorders, anxiety and/or nervous agitation', including diagnoses such as somatoform disorders, might more adequately describe what Hypericum extracts are actually used for by many practitioners. The exact mechanisms of action are still unclear, but the available research clearly shows that various bioactive constituents contribute to the clinical effects reported, often in a synergistic manner. Hypericum extracts have consistently shown activity in pharmacological models related to antidepressant effects. Randomized clinical trials show that Hypericum extracts are more effective than placebo and similarly effective as standard antidepressants while having better tolerability in the acute treatment of major depressive episodes. The most important risk associated with Hypericum extracts are interactions with other drugs. Therefore, physicians need to be informed whether their patients take St. John's wort products. If the risk of interactions is adequately taken into account, high quality Hypericum extracts are an effective and safe tool in the hand of qualified health profession-als in primary care. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657198     DOI: 10.1159/000209290

Source DB:  PubMed          Journal:  Forsch Komplementmed        ISSN: 1661-4119


  18 in total

1.  Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine.

Authors:  Peggy Jungke; Gigi Ostrow; Jian-Liang Li; Sharon Norton; Karen Nieber; Olaf Kelber; Veronika Butterweck
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

Review 2.  Xenohormesis: health benefits from an eon of plant stress response evolution.

Authors:  Philip L Hooper; Paul L Hooper; Michael Tytell; Lászlo Vígh
Journal:  Cell Stress Chaperones       Date:  2010-06-04       Impact factor: 3.667

3.  A Case of Panic Attack Induced by St John's Wort.

Authors:  Osman Yildirim; Fatih Canan
Journal:  Prim Care Companion CNS Disord       Date:  2013

4.  Treatment of depressive disorders in primary care--protocol of a multiple treatment systematic review of randomized controlled trials.

Authors:  Klaus Linde; Isabelle Schumann; Karin Meissner; Susanne Jamil; Levente Kriston; Gerta Rücker; Gerd Antes; Antonius Schneider
Journal:  BMC Fam Pract       Date:  2011-11-15       Impact factor: 2.497

5.  Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.

Authors:  Julia Sacher; Sylvain Houle; Jun Parkes; Pablo Rusjan; Sandra Sagrati; Alan A Wilson; Jeffrey H Meyer
Journal:  J Psychiatry Neurosci       Date:  2011-11       Impact factor: 6.186

6.  Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.

Authors:  Siegfried Kasper
Journal:  Wien Med Wochenschr       Date:  2015-06-20

7.  Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report.

Authors:  Stefanie Schreiber; Vanessa Prox-Vagedes; Erck Elolf; Ines Brueggemann; Guenther Gademann; Imke Galazky; Claudius Bartels
Journal:  BMC Cancer       Date:  2010-10-01       Impact factor: 4.430

8.  The effect of Hypericum Perforatum on wound healing of oral mucosa in diabetic rats.

Authors:  Ahmet Altan; Mutan Hamdi Aras; İbrahim Damlar; Hasan Gökçe; Oğuzhan Özcan; Cansu Alpaslan
Journal:  Eur Oral Res       Date:  2018-09-01

Review 9.  Molecular targets of statins and their potential side effects: Not all the glitter is gold.

Authors:  Kush K Patel; Viren S Sehgal; Khosrow Kashfi
Journal:  Eur J Pharmacol       Date:  2022-03-20       Impact factor: 4.432

Review 10.  Dietary and botanical anxiolytics.

Authors:  Elham Alramadhan; Mirna S Hanna; Mena S Hanna; Todd A Goldstein; Samantha M Avila; Benjamin S Weeks
Journal:  Med Sci Monit       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.